MedPath

Precision Gait Retraining for Children With Cerebral Palsy

Not Applicable
Completed
Conditions
Gait Disorders, Neurologic
Cerebral Palsy
Interventions
Device: mPAD (or TPAD) Pelvic Assist Device
Device: No Intervention
Registration Number
NCT04717323
Lead Sponsor
Altec Inc.
Brief Summary

This project will develop the first sensor-based mobile Pelvic Assist Device (mPAD) that can deliver precise, adaptable, pelvic control to restore natural coordination of upper- and lower-limb movements during gait in children with Cerebral Palsy

Detailed Description

Gait impairments hinder mobility for more than 760,000 children and adults living with cerebral palsy (CP) in the US. Motor relearning is possible for these individual but typically requires numerous training sessions with a team of physical therapists and assistants to restore coupling between upper- and lower-body segments while assisting spastic uncoordinated limb movement to improve gait kinematics. This clinical trial will meet the overall objective of testing the feasibility of developing a smart-robotic exoskeleton that is effective at providing guided pelvic assistance and support while biofeedback mediated training is facilitated under the supervision of a physiotherapist. The project will test a novel tethered Pelvic Assist Device (TPAD) with integratable electromyographic (EMG) and inertial (IMU) biofeedback that is uniquely capable of delivering precise, adaptable, multi-degree-of-freedom pelvic control to promote natural intersegmental coupling, restore coordination of upper- and lower-limb movement, and improve normal gait kinematics in children with CP. Because of its proximity to the center of mass and critical role in coordinating upper- and lower-limb control, the pelvis provides an ideal access point for physiotherapists to manually improve gait. The investigators will test the hypothesis that accurate sensor-based metrics of gait can be derived from EMG and IMU wearable sensors to develop a biofeedback system for motor learning that are integratable with TPAD to develop a new mobile mPAD device that is compliant with the target population.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PatientsNo InterventionGait with and without pelvic assistance
PatientsmPAD (or TPAD) Pelvic Assist DeviceGait with and without pelvic assistance
ControlsNo InterventionGait with no pelvic assistance
Primary Outcome Measures
NameTimeMethod
Rating of Perceived Difficulty1 day

Structured interviews will be used to grade the perception of difficulty in using the technology

Knee Range of Motion During Walking1 day

Difference (in degrees) between knee range of motion during walking as detected by wearable sensors and motion capture

Gait Metric Accuracy1 day

Measures the accuracy of identifying heel strike and toe off timing in % error when comparing measures from wearable sensors vs. motion capture

Pelvis Range of Motion During Walking1 day

Difference (in degrees) between pelvis range of motion during walking as detected by wearable sensors and motion capture

Muscle Activation During Walking1 day

Measures electromyographic (EMG) signals of trunk and lower limb muscles during gait which are necessary for designing and implementing a mobile pelvic assist device (mPAD) system with biofeedback

Trunk Range of Motion During Walking1 day

Difference (in degrees) between trunk range of motion during walking as detected by wearable sensors and motion capture

Hip Range of Motion During Walking1 day

Difference (in degrees) between hip range of motion during walking as detected by wearable sensors and motion capture

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Altec Inc.

🇺🇸

Natick, Massachusetts, United States

CUMC Harkness Pavillion

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath